Q&A: A Molecular Toolkit to Build SARS-CoV-2 Research Capacity
Q&A: A Molecular Toolkit to Build SARS-CoV-2 Research Capacity
Sam Wilson discusses a user-friendly set of resources that he and his collaborators developed to aid labs pivoting to study COVID-19.
Q&A: A Molecular Toolkit to Build SARS-CoV-2 Research Capacity
Q&A: A Molecular Toolkit to Build SARS-CoV-2 Research Capacity

Sam Wilson discusses a user-friendly set of resources that he and his collaborators developed to aid labs pivoting to study COVID-19.

Sam Wilson discusses a user-friendly set of resources that he and his collaborators developed to aid labs pivoting to study COVID-19.

disease & medicine
Frontiers Removes Controversial Ivermectin Paper Pre-Publication
Frontiers Removes Controversial Ivermectin Paper Pre-Publication
Catherine Offord | Mar 2, 2021
A review article containing contested claims about the tropical medicine drug as a COVID-19 treatment was listed as “provisionally accepted” on the journal’s website before being removed this week.
Variant Found in Brazil Could Evade Immunity from Past Infection
Variant Found in Brazil Could Evade Immunity from Past Infection
Lisa Winter | Mar 2, 2021
The P.1 variant, which has also been detected in five US states, could be responsible for cases of reinfection, according to a preprint.
Regeneron Cocktail Stumbles Against SARS-CoV-2 Variant in Vitro
Regeneron Cocktail Stumbles Against SARS-CoV-2 Variant in Vitro
Marcus A. Banks | Mar 1, 2021
A treatment of two monoclonal antibodies against SARS-CoV-2 is ninefold less effective in the lab against the B.1.351 variant than against the dominant version of the virus.
US Authorizes a Third COVID-19 Vaccine
US Authorizes a Third COVID-19 Vaccine
Asher Jones | Mar 1, 2021
Johnson & Johnson’s one-shot immunization could reach people’s arms as early as March 2.
Infographic: Envisioning Macrophages
Infographic: Envisioning Macrophages
Ashley Yeager | Mar 1, 2021
Researchers find different distributions of the immune cells in young, older, and diseased eyes.
Infographic: How SARS-CoV-2 Immune Responses May Differ by Sex
Infographic: How SARS-CoV-2 Immune Responses May Differ by Sex
Catherine Offord | Mar 1, 2021
Males and females show differences in gene expression, cell activation, and antibody production in response to some viral infections, but whether these influence COVID-19 outcomes is still unclear.
Macrophages of the Human Eye Come into Focus
Macrophages of the Human Eye Come into Focus
Ashley Yeager | Mar 1, 2021
Imaged in real time in living people, immune cells at the surface of the retina could serve as biomarkers to detect retinal and possibly neurological diseases and track their progression.
COVID-19 Hospitalizations Tank a Month After Vaccines Roll Out
COVID-19 Hospitalizations Tank a Month After Vaccines Roll Out
Asher Jones | Feb 23, 2021
Two preliminary reports from the UK provide real-world evidence in support of the Pfizer/BioNTech and Oxford-AstraZeneca vaccines.
Organoids Repair Bile Ducts
Organoids Repair Bile Ducts
Abby Olena | Feb 18, 2021
Researchers determined that when introduced into damaged mouse or donated human livers, these lab-grown tissues could integrate into bile ducts and function normally.